BRAMBLES LIMITED (BXB)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

BXB

BXB - BRAMBLES LIMITED

FNArena Sector : Transportation & Logistics
Year End: June
GICS Industry Group : Commercial & Professional Services
Debt/EBITDA: 1.44
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Brambles is an Australian supply-chain logistics company operating in more than 50 countries. It provides unit-load equipment, pallets, crates and containers to the global transport sector. It first listed on the Australian Securities Exchange in 1954.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$20.80

02 May
2025

0.230

OPEN

$20.72

1.12%

HIGH

$20.80

2,620,627

LOW

$20.45

TARGET
$21.942 5.5% upside
Franking for last dividend paid out: 30%
OTHER COMPANIES IN THE SAME SECTOR
ACE . AIZ . AQZ . AVD . AZJ . CLX . ERD . KLS . KSC . LAU . NTD . QAN . QUB . SLH . SPZ . SST . THL . WTC . Z2U .
FNARENA'S MARKET CONSENSUS FORECASTS
BXB: 1
Title FY25
Forecast
FY26
Forecast
EPS (cps) 94.1 xxx
DPS (cps) 58.4 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 22.2 xxx
Dividend Yield 2.8% xxx
Div Pay Ratio(%) 62.1% xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 4.95%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

2.51

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 11/09 - ex-div 28.90c (franking 35%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx85.5
DPS All xxxxxxxxxxxxxxx52.0
Sales/Revenue xxxxxxxxxxxxxxx9,988.6 M
Book Value Per Share xxxxxxxxxxxxxxx347.0
Net Operating Cash Flow xxxxxxxxxxxxxxx2,753.6 M
Net Profit Margin xxxxxxxxxxxxxxx11.92 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx26.03 %
Return on Invested Capital xxxxxxxxxxxxxxx14.71 %
Return on Assets xxxxxxxxxxxxxxx8.57 %
Return on Equity xxxxxxxxxxxxxxx26.03 %
Return on Total Capital xxxxxxxxxxxxxxx17.55 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx400.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx234 M
Long Term Debt xxxxxxxxxxxxxxx3,720 M
Total Debt xxxxxxxxxxxxxxx3,954 M
Goodwill - Gross xxxxxxxxxxxxxxx278 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx169 M
Price To Book Value xxxxxxxxxxxxxxx4.19

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx1,753.6 M
Capex % of Sales xxxxxxxxxxxxxxx17.56 %
Cost of Goods Sold xxxxxxxxxxxxxxx7,969 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx490 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx227 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.7

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

29/04/2025

1

Buy

$23.00

10.58%

UBS notes Brambles' group sales in 3Q25 were -1% lower on volume in contrast to the 4% average growth over the preceding four quarters. The company narrowed FY25 sales guidance to 4-5%, which points to a sharp improvement in 4Q from the soft trend in the first nine months.

The broker is forecasting 3.7% sales growth on an expectation of improvement from new business volume, and lifted free cash flow estimate on lower capex and asset productivity benefits.

Buy retained. Target lifted to $23.00 from $22.80.

FORECAST
UBS forecasts a full year FY25 dividend of 57.00 cents and EPS of 92.00 cents.
UBS forecasts a full year FY26 dividend of 64.00 cents and EPS of 101.00 cents.

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Goldman Sachs

xx/xx/xxxx

5

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

30/04/2025

3

Neutral

$19.80

-4.81%

Jarden notes Brambles reported 9-month constant-currency revenue growth of 3%, comprising 2% price and 1% volume, though FY25 revenue guidance was trimmed to 4–5% from 4–6% due to volume headwinds.

The analyst highlights unchanged FY25 EBIT growth guidance of 8–11%, driven by cost reductions including lower inventory pooling equipment expense and corporate overheads, though questions remain around sustainability into FY26.

Management's free cash flow guidance was raised to US$900m–US$1bn, supporting an anticipated US$500m buyback in FY26.

Jarden lifts FY25–FY27 core EPS forecasts modestly and maintains the view that a reversion to normal operating conditions is occurring faster than expected. Neutral rating and $19.80 target price are retained.

FORECAST
Jarden forecasts a full year FY25 dividend of 37.70 cents and EPS of 93.31 cents.
Jarden forecasts a full year FY26 dividend of 40.20 cents and EPS of 103.61 cents.

BXB STOCK CHART